EAPM has identifies 5 STEPs towards a healthier Europe. This has the goal of securing patients' quality of life through Personalised Medicine.
STEP 1 - Ensuring a regulatory environment which allows early patient access to novel and efficacious personalised medicine.
STEP 2 - Increasing research and development for PM, while recognising its value
STEP 3 - Improving the education and training of healthcare professionals
STEP 4 - Supporting new approaches to reimbursement and HTA assessment, required for patient access to PM
STEP 5 - Increasing awareness and understanding of PM